Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Business Wire
25m
Enanta Pharmaceuticals to Present Topline Results from First-in-Pediatrics Phase 2 Study Evaluating Zelicapavir for Respiratory Syncytial Virus (RSV)
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for virology and immunol ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Manslaughter dropped
US adds 227,000 jobs
Family awarded $310 million
Taking extended leave
Chinese vessel hijacked
Climbers feared dead
Havana syndrome report
Federal fraud charges arrest
Drops bid for third term
Use of race in admissions OK'd
Trump shows public support
‘One Life to Live’ star dies
White Sox legend dies
Oven gloves recalled
Blackhawks fire coach
Messi wins MLS MVP award
Hit six months in space
NY museum unveils 'Apex'
Mandates nationwide milk test
Appeals court upholds ban
Hired as Utah State coach
Wild bird lays egg at 74
Promotes trade w/ Mexico
'Patriot of the Year' award
Massive fire in Baltimore
Iran: Space launch successful
NBA returning to China
AI bias meter coming
Recalls 300K+ Ram trucks
Scott tapped to lead CBP
Pledges hit $100 billion
Romanian election annulled
Related topics
United States
RSV
Feedback